DRUG DISCOVERY FEATURED ARTICLES & APPLICATIONS

• 

  Inflammation And The New Drug Development Paradigm

  Opportunities abound for new treatments for inflammatory diseases, which afflict millions of people. Upward spiraling development costs, however, impede progress and delay relief for patients suffering from such debilitating diseases. By Thomas Vihtelic, DVM, PhD, MPI Research

• Vaccine Potential And Preclinical Development Needs

  Few medical advances have made as large an impact on world health as vaccines. Globally, Vaccines prevent approximately 10.5 million cases of infectious illness each year. 2.5 million child deaths are prevented from diphtheria, tetanus, pertussis, and measles annually through immunization (BIO). Despite these facts, infectious diseases are still the second leading cause of death worldwide, and new infectious diseases continue to emerge. By Stephene Rose; Senior Study Director at MPI Research

• Automation Of Cell Staining

  Automation with the Biomek 4000 platform can improve the throughput and reproducibility of conventional staining of adherent cells. Applicability is demonstrated using mouse embryonic stem cells (mESCs) to detect the expression of developmental antigens in fixed cells following differentiation to cardiomyocytes which is relevant to stem cell biology research. By Amy N. Yoder and Li Liu, Beckman Coulter Life Sciences

• Despite The Presence Of Typhoon Vincente, Good Teamwork And Communication Made A Valuable Pharmaceuticals Shipment From Toronto To Sydney Possible

  Hong Kong was lashed by Typhoon Vicente, the first level 10 typhoon in 13 years, which brought air traffic at Hong Kong International Airport to a halt. While a delayed flight can be a major inconvenience for passengers, for extremely valuable pharmaceutical shipments that must be kept at a narrow band of controlled temperature, delays can be catastrophic.

• How Do I Get My Compound Into Phase I?

  The primary challenge for pharmaceutical and biotechnology companies in developing their drugs is to carefully assess the relationship between efficacy and toxicity prior to entering into human clinical trials. By Dr. Scott E. Boley and Greg Ruppert

LATEST NEWS

• Agilux Laboratories Announces Space Expansion To Support Increasing Demand For Its In Vivo Pharmacokinetics Services

  Agilux Laboratories, a leading provider of Drug Metabolism and Pharmacokinetics (DMPK) services to pharmaceutical and biotechnology firms, announced recently that it has undergone a significant space expansion of its in vivo pharmacokinetics services to support clients’ demands and increased service requirements

• Zyoxel Announces The Performance Of Tests By Sanofi On The Power Of 3D Liver Culture Models For More Predictive And Insightful DMPK Studies
• JHL Biotech, Inc. And Selexis SA Form Biologic Drug Development Alliance To Serve The Biopharmaceutical Industry
• USP Announces PharmaCheck Drug Quality Screening Technology Recognized Among “World Changing Ideas Of 2013”
• Zalviso™ New Drug Application Accepted For Filing By FDA

FEATURED PRODUCTS AND SERVICES

Analytical Method Development & Validation

Patheon offers the full breadth of advanced analytical technologies for support of early-stage formulation for clinical trial materials. 

Azbil BioVigilant’s Investigation Services

In the pharmaceutical industry, product contamination poses a serious risk to manufacturing operations.

Quality Management Software

Using a Quality Management Software System for Automating Paper-Based Quality Management Processes for Companies that Comply with FDA Regulations and that Follow ISO Quality Standards.

Mueller MES-325-6 WFI Distillation Unit (Private Treaty Sale)

Mueller MES-325-6 WFI Distillation Unit (Private Treaty Sale) By GoIndustry DoveBid

HP D300 Digital Dispenser

Fast and accurate determination of a candidate compound’s IC50 provides drug discovery biologists with valuable information for the development of new pharmaceuticals, yet traditional techniques are both time­ consuming and laborious, with no standardization across the industry.

Drug Safety Evaluation

MPI Research offers comprehensive services to help determine the safety of life-changing compounds and assist in bringing them to the marketplace as rapidly as possible.

ARCHIVED NEWSLETTER

• 12.06.13 -- Report: Pharma Should Factor Medication Adherence Into Drug Development
• 11.01.13 -- Strategic Alliance Formed To Fight Counterfeit Drugs
• 10.04.13 -- First Drug Approved For Use In Preoperative Breast Cancer
• PerFix Reagent Kits Deliver Probes, Antibodies Into Cells
• 08.02.13 -- Advancement Of Predictive Drug Safety Systems Announced